CD274 and invasive ductal breast carcinoma: Similarly, analysis of 136 samples of invasive ductal carcinoma showed that TNBC has higher proportions of positive samples for PD-1 (43.5 versus 29.4% among the entire cohort) and TC PD-L1 (47.8 versus 33.1% among the entire cohort).